These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 25953102)

  • 1. Azacytidine sensitizes acute myeloid leukemia cells to arsenic trioxide by up-regulating the arsenic transporter aquaglyceroporin 9.
    Chau D; Ng K; Chan TS; Cheng YY; Fong B; Tam S; Kwong YL; Tse E
    J Hematol Oncol; 2015 May; 8():46. PubMed ID: 25953102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of expression of aquaglyceroporin 9 with arsenic uptake and sensitivity in leukemia cells.
    Leung J; Pang A; Yuen WH; Kwong YL; Tse EW
    Blood; 2007 Jan; 109(2):740-6. PubMed ID: 16968895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 19-Nor-1,25(OH)2D2 (a novel, noncalcemic vitamin D analogue), combined with arsenic trioxide, has potent antitumor activity against myeloid leukemia.
    Kumagai T; Shih LY; Hughes SV; Desmond JC; O'Kelly J; Hewison M; Koeffler HP
    Cancer Res; 2005 Mar; 65(6):2488-97. PubMed ID: 15781666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of arsenic trioxide-induced apoptosis in renal cell carcinoma cells by L-buthionine sulfoximine.
    Wu XX; Ogawa O; Kakehi Y
    Int J Oncol; 2004 Jun; 24(6):1489-97. PubMed ID: 15138592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbonyl reductase 1 offers a novel therapeutic target to enhance leukemia treatment by arsenic trioxide.
    Jang M; Kim Y; Won H; Lim S; K R J; Dashdorj A; Min YH; Kim SY; Shokat KM; Ha J; Kim SS
    Cancer Res; 2012 Aug; 72(16):4214-24. PubMed ID: 22719067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-simulating agents and selective stimulation of arsenic trioxide-induced growth arrest and cell differentiation in acute promyelocytic leukemic cells.
    Yan H; Peng ZG; Wu YL; Jiang Y; Yu Y; Huang Y; Zhu YS; Zhao Q; Chen GQ
    Haematologica; 2005 Dec; 90(12):1607-16. PubMed ID: 16330433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic antitumor activity of oridonin and arsenic trioxide on hepatocellular carcinoma cells.
    Chen G; Wang K; Yang BY; Tang B; Chen JX; Hua ZC
    Int J Oncol; 2012 Jan; 40(1):139-47. PubMed ID: 21947421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-azacytidine enhances efficacy of multiple chemotherapy drugs in AML and lung cancer with modulation of CpG methylation.
    Füller M; Klein M; Schmidt E; Rohde C; Göllner S; Schulze I; Qianli J; Berdel WE; Edemir B; Müller-Tidow C; Tschanter P
    Int J Oncol; 2015 Mar; 46(3):1192-204. PubMed ID: 25501798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenic trioxide inhibits DNA methyltransferase and restores TMS1 gene expression in K562 cells.
    Li H; Wang Y; Xu W; Dong L; Guo Y; Bi K; Zhu C
    Acta Haematol; 2015; 133(1):18-25. PubMed ID: 24993472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of arsenic trioxide administration styles on leukocytosis.
    Zhou J; Meng R; Sui XH; Meng L; Yang BF
    Chin Med Sci J; 2006 Jun; 21(2):111-4. PubMed ID: 16845799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arsenic trioxide suppresses thymidylate synthase in 5-FU-resistant colorectal cancer cell line HT29 In Vitro re-sensitizing cells to 5-FU.
    Subbarayan PR; Lee K; Ardalan B
    Anticancer Res; 2010 Apr; 30(4):1157-62. PubMed ID: 20530422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trolox enhances the anti-lymphoma effects of arsenic trioxide, while protecting against liver toxicity.
    Diaz Z; Laurenzana A; Mann KK; Bismar TA; Schipper HM; Miller WH
    Leukemia; 2007 Oct; 21(10):2117-27. PubMed ID: 17690699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of arsenic trioxide (As2O3) on leukemic cells from patients with non-M3 acute myelogenous leukemia: studies of cytotoxicity, apoptosis and the pattern of resistance.
    Lehmann S; Bengtzen S; Paul A; Christensson B; Paul C
    Eur J Haematol; 2001 Jun; 66(6):357-64. PubMed ID: 11488934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aquaporin 9, a promising predictor for the cytocidal effects of arsenic trioxide in acute promyelocytic leukemia cell lines and primary blasts.
    Iriyama N; Yuan B; Yoshino Y; Hatta Y; Horikoshi A; Aizawa S; Takeuchi J; Toyoda H
    Oncol Rep; 2013 Jun; 29(6):2362-8. PubMed ID: 23563754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arsenic trioxide re-sensitizes ERα-negative breast cancer cells to endocrine therapy by restoring ERα expression in vitro and in vivo.
    Zhang W; Wang L; Fan Q; Wu X; Wang F; Wang R; Ma Z; Yang J; Lu SH
    Oncol Rep; 2011 Sep; 26(3):621-8. PubMed ID: 21687957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of intracellular arsenic trioxide for therapeutic response in acute promyelocytic leukemia.
    Sahu GR; Jena RK
    Am J Hematol; 2005 Feb; 78(2):113-6. PubMed ID: 15682419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The expression of AQP9 in HepG2 cells affects cell biological behaviors and sensitivity to As2O3].
    Tang J; Wang C; Jiang Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jun; 31(6):769-74. PubMed ID: 26062419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphoinositide 3-kinase/Akt inhibition increases arsenic trioxide-induced apoptosis of acute promyelocytic and T-cell leukaemias.
    Tabellini G; Tazzari PL; Bortul R; Evangelisti C; Billi AM; Grafone T; Martinelli G; Baccarani M; Martelli AM
    Br J Haematol; 2005 Sep; 130(5):716-25. PubMed ID: 16115127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arsenic trioxide downregulates the expression of annexin II in bone marrow cells from patients with acute myelogenous leukemia.
    Zhang XH; Hu Y; Bao L; Jiang Q; Yang LH; Lu XJ; Hong M; Xia LH; Guo T; Shen GX; Zhu HH; Zhao T; Song SJ
    Chin Med J (Engl); 2009 Sep; 122(17):1969-73. PubMed ID: 19781379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte colony-stimulating factor potentiates differentiation induction by all-trans retinoic acid and arsenic trioxide and enhances arsenic uptake in the acute promyelocytic leukemia cell line HT93A.
    Iriyama N; Yuan B; Hatta Y; Horikoshi A; Yoshino Y; Toyoda H; Aizawa S; Takeuchi J
    Oncol Rep; 2012 Nov; 28(5):1875-82. PubMed ID: 22940758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.